Status: current, Sufficiently defined by necessary conditions definition status. Date: 28-Feb 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4945155010 | Ambroxol hydrochloride 3 mg/mL and guaifenesin 10 mg/mL and terbutaline sulfate 250 microgram/mL oral solution | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4952187014 | Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has manufactured dose form | Conventional release oral solution | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Plays role | Expectorant therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Plays role | Mucolytic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has precise active ingredient | Terbutaline sulfate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has basis of strength substance | Terbutaline sulfate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has concentration strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has precise active ingredient | Ambroxol hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has basis of strength substance | Ambroxol hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has precise active ingredient | Guaifenesin | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has basis of strength substance | Guaifenesin | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely ambroxol hydrochloride 3 milligram/1 milliliter and guaifenesin 10 milligram/1 milliliter and terbutaline sulfate 250 microgram/1 milliliter conventional release oral solution (clinical drug) | Is a | Product containing only ambroxol and guaifenesin and terbutaline in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR